A5101622805- Tuberculosis Research and Epidemiology
- COVID-19 epidemiological studies
- Pneumonia and Respiratory Infections
- Diagnosis and treatment of tuberculosis
- COVID-19 Pandemic Impacts
- Parasites and Host Interactions
- COVID-19 Clinical Research Studies
- COVID-19 diagnosis using AI
- HIV/AIDS Impact and Responses
- Delphi Technique in Research
- Global Health and Surgery
- Respiratory viral infections research
All India Institute of Medical Sciences
2024-2025
Ministry of Health and Family Welfare
2025
McGill University
2021
Tuberculosis (TB) is the leading infectious disease cause of death worldwide. In recent years, stringent measures to contain spread SARS-CoV-2 have led considerable disruptions healthcare services for TB in many countries. The extent which these affected testing, treatment initiation and outcomes has not been comprehensively assessed. We aimed estimate service occurring during COVID-19 pandemic Brazil, India, South Africa. obtained country-level programme laboratory data used autoregressive...
The COVID-19 pandemic has impacted health systems and programs across the world. For tuberculosis (TB), it is predicted to set back progress by at least twelve years. Public private mix (PPM)has made a vital contribution reach End TB targets with ten-fold rise in notifications from providers between 2012 2019. This due large part efforts of intermediary agencies, which aggregate demand providers. put these gains risk over past year. In this rapid assessment, representatives 15 agencies seven...
The burden of tuberculosis (TB) is disproportionate in tropical and subtropical regions, where parasitic coinfections are common. Given the significant geographical overlap between TB intestinal infections, it important to consider implications infections for pandemic. Intestinal have been theorized increase vulnerability by altering inflammatory milieu, inducing undernutrition that blunts immune response, affecting drug pharmacokinetics. In this perspective piece, we provide a background...
Abstract Tuberculosis (TB) is the leading infectious disease cause of death worldwide. In recent years, stringent measures to contain spread SARS-CoV-2 have led considerable disruptions healthcare services for TB in many countries. The extent which these affected testing, treatment initiation and outcomes has not been comprehensively assessed. We aimed estimate service occurring during COVID-19 pandemic Brazil, India, South Africa. obtained country-level programme laboratory data used...